Register to get free articles
Want unlimited access? View Plans
Already have an account? Sign in
Medical technology group, Smith+Nephew, has announced that Graham Baker will step down from the board as chief financial officer on 30 April 2020.
Following his departure, he will take up a new CFO role outside of the healthcare sector.
Smith+Nephew said it is now at an “advanced stage” of appointing a new CFO, and expects to announce Baker’s successor “in the near future”.
Senior vice president of group finance, Ian Melling, will serve as interim CFO following Baker’s departure, and join the executive committee but not the board during this period.
Roland Diggelmann, CEO at Smith+Nephew, said: “Graham has been a highly valued member of our team and has been instrumental in many of the changes that are supporting our recent improved performance.
“He leaves with our very best wishes for the future. We are confident that we will be able to announce Graham’s replacement shortly and that this will be a proven CFO with excellent global listed-company and healthcare experience.”
Baker added: “I am immensely proud of what Smith+Nephew, and the finance and IT teams in particular, have achieved over the last three years and I appreciate very much the opportunity I have had to work with Roland, both as board member and CEO.
“While I regret not being able to continue the great work we have started, my new opportunity was too compelling personally and professionally to miss.”
